Could DTC Move the Numbers for Sanofi and MNKD?

[spiro]

It is  Spiro's opinion that DTC will be successful, particularly with the older population. A lot of older diabetics, don't Twitter, Facebook or e-mail, heck they don't even own a computer, but they do sit around and watch TV all day. Spiro has three Type 2 diabetic friends, none of them use a computer at home and none of them have a copy of their recent lab reports or A1c reports.

Friend #1, late 70s, Type 2, does not know the name of his diabetes meds or latest A1c result.

Friend #2, early 70's, Type 2, Also knows nothing, bought a laptop 6 months ago, but doesn't use the free internet from her cable provider fearing a virus?

Friend #3, early 70's, Type 2, Started on Metformin by PCP over 2 years ago, after A1c went over 8, he was referred to an Endo.  His endo doubled his Metformin and started him on Victoza. He also does not ask for copies of his lab reports. He mentioned all of the bad side effects of Victoza and was going to discuss them with his Endo. 

Spiro has shared his Afrezza story with all three of them and encouraged them to find out more about Afrezza. It's amazing how many seniors are oblivious to treatment alternatives. You know, 4 months ago Spiro actually thought that he was in worst shape than all three of them. His A1c was 7.1 and rising and he had pathetic lab reports.  Now 4 months after starting Afrezza, He is sitting on a 6.2 A1c and dropping, with the remainder of his important blood tests being at normal levels for the first time in over 20 years. it sure seems like Afrezza has given Spiro the ability to manage his diabetes quite well and hopefully slow down it's progression. It's most unfortunate that Spiro's three good friends do not appear to be listening. Maybe one day, they will believe a TV advertisement.

Spiro is not certain that print media will be too successful targeting seniors, it will take TV ads to get to most of them. Last week, Spiro was sitting in his doctor's office with 5 or 6 other old farts for over 2 hours and not one of us picked up a magazine to read. Everyone knows that touching magazines in a doctor's office, literally invites disease into one's body. That would include touching door handles, counter tops and anything else. 

Spiro here, lying low and trying to keep out of trouble, after getting the Lead position. Dang, it's really tough

[notamnkdmillionaire]

By the time they get the RX for Afrezza, will they even remember to take it let alone they are ill?

[sportsrancho]

Friend #1 Type 2. Does not know the name of the pills he's on. Or his A1c. Has a computer but does not read social media. 47 years old and has a hard time reading. Friend #2. Can't feel his feet anymore. Type2. Does not know what pills he is on or his A1c other than it is to high and he was told lose weight. Does not have a computer or a cell phone. Friend #3. 83 year old women. Type2. Does not know what she is on or her numbers. But her feet are so bad she has a hard time walking. Does not have a PC and only has a flip phone. TV is the only way to reach these people!!! Spiro is so right! And they don't read magazines in doctors offices. Or like to question their doctors. Getting the doc's on board. And TV ..TV....TV !!! sports

[ashiwi]

Spiro, for such a young lady's man like yourself, you are certainly hanging out with some old friends.

I agree, Afrezza would be an easy sell on TV. Let's hope that SNY goes all in and gives Afrezza the opportunity to be the blockbuster that it has the potential to be.

The glucose spikes are what ultimately causes the foot neuropathy . So easy to prevent with Afrezza early on. Treating pre-diabetics (with Afrezza) can ultimately save the healthcare system billions of dollars. Al Mann was right when he said Afrezza can reverse diabetes in type 2 if caught early.
Spiro's numbers are living proof.

[joeypotsandpans]

Currently have a diabetic educator client that called me yesterday to tell me about seeing the article and ad in diabetic forecast magazine. The "DTC" may or may not get read by diabetics sitting in waiting rooms just as if not more importantly, the educators and prescribers ARE reading them .

Very appropriate holiday this weekend, let the fireworks begin...starting next week I am as convinced as ever that the "right" inverse shoulder from a pattern over 8yrs. in the making will be commencing. I would not be surprised to see a gap up come Monday, the reps were definitely getting their 2nd Q numbers pushed before the 30th on Tues. so not surprising to see scripts start jumping either. As mentioned in other thread, expect studies to start coming out beginning in Aug. that illustrate what most us have known for a long time, that is, the true benefits of Afrezza regarding REDUCED hypo risk, etc. These will go a long way in alleviating the dosing confusion remarks that Sam alone has tried to combat.

My tagline has been "wake me up when it's over" ...well me eyes are on the "brink" of starting to open! Enjoy the fireworks this weekend and the continued show the rest of this month and beyond.

[dreamboatcruise]

It isn't many of those patients mentioned that are being targeted now. The ones being targeted now are people that will nudge overworked doctors into actually becoming educated about Afrezza (and the health professionals themselves as Joey points out). The real mass market DTC will wait for more doctors to be on board and for the restrictions in formularies to loosen up.

But we're already seeing Afrezza spiking in google searches (I posted on another thread on that), so this ad appears to be generating results.

Unlike RVW... I'm fully awake and finding the Afrezza journey an interesting one. I long ago managed to tune out the FUD.